La catena delle opzioni mostra i dati chiave delle opzioni azionarie di MeiraGTx Hldgs a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per MeiraGTx Hldgs..

MeiraGTx Hldgs (NASDAQ:MGTX) Azioni, Catena delle Opzioni

MeiraGTx Hldgs

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

MeiraGTx Holdings PLC

CLSA analyst Max Hopkins maintains Oklo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) with a Outperform and raises the price target from $50 to $74.

News

Price Target

Analyst Ratings

OKLO

CLSA Maintains Outperform on Oklo, Raises Price Target to $74

<h3>Gainers</h3>
<ul>
<li>SharpLink Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) shares increased by 459.7% to $37.61 during Tuesday's regular session. The market value of their outstanding shares is at $24.8 million. </li>
<li>LiveWire Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVWR#NYSE">LVWR</a>) stock moved upwards by 118.81% to $2.21. The market value of their outstanding shares is at $449.8 million. </li>
<li>E-Home Household Service (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EJH#NASDAQ">EJH</a>) stock moved upwards by 52.67% to $0.15. The market value of their outstanding shares is at $1.3 million. </li>
<li>iRobot (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRBT#NASDAQ">IRBT</a>) shares rose 43.06% to $3.69. The market value of their outstanding shares is at $113.0 million. </li>
<li>NWTN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTN#NASDAQ">NWTN</a>) stock rose 26.62% to $2.14. The company's market cap stands at $612.4 million. </li>
<li>Vision Marine Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMAR#NASDAQ">VMAR</a>) stock increased by 18.82% to $7.6. The market value of their outstanding shares is at $8.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>QVC Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QVCGP#NASDAQ">QVCGP</a>) shares declined by 50.5% to $7.63 during Tuesday's regular session. </li>
<li>Jeffs Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFBR#NASDAQ">JFBR</a>) stock declined by 28.15% to $0.55. The market value of their outstanding shares is at $2.1 million. </li>
<li>Nova Lifestyle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVFY#NASDAQ">NVFY</a>) stock decreased by 18.69% to $1.2. The market value of their outstanding shares is at $16.4 million. </li>
<li>Champion Homes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKY#NYSE">SKY</a>) stock decreased by 16.03% to $70.76. The market value of their outstanding shares is at $4.0 billion. As per the press release, Q4 earnings came out today. </li>
<li>PDD Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) stock decreased by 15.55% to $100.71. The company's market cap stands at $142.9 billion. As per the press release, Q1 earnings came out today. </li>
<li>Netclass Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTCL#NASDAQ">NTCL</a>) shares declined by 14.42% to $3.77. The company's market cap stands at $67.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

IRBT

JFBR

LVWR

NTCL

NVFY

NWTN

Citigourp Global Markets 2% Protected Notes Linked To The Djia

QVCGP

SBET

VMAR

12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>SCWorx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WORX#NASDAQ">WORX</a>) shares rose 60.0% to $0.64 during Tuesday's regular session. The market value of their outstanding shares is at $2.3 million. </li>
<li>Forte Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBRX#NASDAQ">FBRX</a>) stock rose 40.28% to $11.91. The market value of their outstanding shares is at $78.4 million. </li>
<li>Tonix Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNXP#NASDAQ">TNXP</a>) stock rose 29.08% to $37.34. The company's market cap stands at $273.5 million. </li>
<li>Anteris Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVR#NASDAQ">AVR</a>) stock increased by 27.19% to $4.63. The company's market cap stands at $166.4 million. </li>
<li>Invivyd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVVD#NASDAQ">IVVD</a>) shares moved upwards by 24.24% to $0.93. The company's market cap stands at $111.5 million. </li>
<li>Inotiv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NOTV#NASDAQ">NOTV</a>) shares rose 24.05% to $2.63. The market value of their outstanding shares is at $90.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Rocket Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKT#NASDAQ">RCKT</a>) shares decreased by 61.9% to $2.39 during Tuesday's regular session. The company's market cap stands at $257.2 million. </li>
<li>NeuroPace (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NPCE#NASDAQ">NPCE</a>) shares declined by 34.0% to $11.67. The company's market cap stands at $382.7 million. </li>
<li>Prothena Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTA#NASDAQ">PRTA</a>) stock fell 30.95% to $4.54. The company's market cap stands at $244.5 million. </li>
<li>Savara (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVRA#NASDAQ">SVRA</a>) stock decreased by 30.64% to $1.97. The market value of their outstanding shares is at $340.4 million. </li>
<li>EXoZymes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXOZ#NASDAQ">EXOZ</a>) shares declined by 26.31% to $10.98. The market value of their outstanding shares is at $91.8 million. </li>
<li>RAPT Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPT#NASDAQ">RAPT</a>) stock fell 20.01% to $0.98. The market value of their outstanding shares is at $130.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EXOZ

FBRX

IVVD

NOTV

NPCE

PRTA

RAPT

RCKT

SVRA

TNXP

WORX

12 Health Care Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Lavoro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVRO#NASDAQ">LVRO</a>) stock rose 74.6% to $4.19 during Tuesday's regular session. The market value of their outstanding shares is at $488.5 million. </li>
<li>OFA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFAL#NASDAQ">OFAL</a>) shares increased by 27.34% to $6.1. The market value of their outstanding shares is at $81.5 million. </li>
<li>Roma Green Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROMA#NASDAQ">ROMA</a>) shares rose 26.48% to $2.91. The market value of their outstanding shares is at $45.2 million. </li>
<li>Innovate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VATE#NYSE">VATE</a>) stock increased by 25.79% to $7.95. The market value of their outstanding shares is at $105.6 million. </li>
<li>Kelly Services (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KELYB#NASDAQ">KELYB</a>) shares increased by 20.7% to $13.7. The market value of their outstanding shares is at $477.9 million. </li>
<li>Captivision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPT#NASDAQ">CAPT</a>) shares moved upwards by 20.64% to $0.55. The company's market cap stands at $17.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Clean Energy Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETY#NASDAQ">CETY</a>) stock declined by 25.5% to $0.29 during Tuesday's regular session. The company's market cap stands at $17.3 million. </li>
<li>Jayud Global Logistics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JYD#NASDAQ">JYD</a>) shares declined by 15.73% to $0.22. The company's market cap stands at $20.2 million. </li>
<li>Webus International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WETO#NASDAQ">WETO</a>) stock decreased by 14.95% to $1.65. The market value of their outstanding shares is at $36.3 million. </li>
<li>Skyline Builders Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKBL#NASDAQ">SKBL</a>) shares declined by 13.42% to $9.1. The company's market cap stands at $275.0 million. </li>
<li>Northann (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NCL#AMEX">NCL</a>) stock decreased by 12.52% to $0.83. The company's market cap stands at $46.2 million. </li>
<li>Eos Energy Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOSE#NASDAQ">EOSE</a>) stock decreased by 11.6% to $5.64. The market value of their outstanding shares is at $1.2 billion. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CAPT

CETY

EOSE

KELYB

LVRO

Nuveen Insured California Premium Fund Ii

OFAL

ROMA

SKBL

VATE

WETO

12 Industrials Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Navitas Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) stock moved upwards by 41.0% to $6.22 during Tuesday's regular session. The market value of their outstanding shares is at $1.1 billion. </li>
<li>E2open Parent Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETWO#NYSE">ETWO</a>) shares rose 25.09% to $3.21. The company's market cap stands at $996.6 million. </li>
<li>BTCS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTCS#NASDAQ">BTCS</a>) shares rose 24.3% to $3.56. The company's market cap stands at $74.9 million. </li>
<li>BigBear.ai Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>) stock moved upwards by 21.52% to $4.42. The company's market cap stands at $1.2 billion. </li>
<li>Signing Day Sports (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SGN#AMEX">SGN</a>) stock rose 18.8% to $0.75. The company's market cap stands at $2.7 million. </li>
<li>Vuzix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VUZI#NASDAQ">VUZI</a>) stock increased by 16.46% to $2.83. The market value of their outstanding shares is at $215.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>UTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) stock declined by 24.6% to $0.87 during Tuesday's regular session. The company's market cap stands at $22.3 million. </li>
<li>MicroAlgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLGO#NASDAQ">MLGO</a>) shares declined by 16.28% to $1.55. The market value of their outstanding shares is at $15.4 million. </li>
<li>Mercurity Fintech Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFH#NASDAQ">MFH</a>) stock fell 15.26% to $3.61. The market value of their outstanding shares is at $229.9 million. </li>
<li>Red Cat Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) stock fell 14.45% to $5.83. The company's market cap stands at $530.4 million. </li>
<li>CISO Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CISO#NASDAQ">CISO</a>) shares fell 10.89% to $1.1. The market value of their outstanding shares is at $35.4 million. </li>
<li>Nukkleus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUKK#NASDAQ">NUKK</a>) stock fell 10.64% to $16.09. The company's market cap stands at $84.8 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BBAI

BTCS

CISO

ETWO

MLGO

NUKK

NVTS

RCAT

VUZI

12 Information Technology Stocks Moving In Tuesday's Intraday Session

Rumors

Trading Ideas

REKR

Watching Rekor Systems; Traders Circulate Popular Newsletter Buys Stock

iShares Trust Dow Jones US Industrial Sector Index Fund

KNSL

URBN

CNBC Halftime Report Final Trades: Kinsale Capital Group, Westinghouse Air Brake Technologies, iShares U.S. Industrials ETF, Urban Outfitters

Financial giants have made a conspicuous bullish move on Starbucks. Our analysis of options history for Starbucks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) revealed 18 unusual trades.
Delving into the details, we found 44% of traders were bullish, while 27% showed bearish tendencies. Out of all the trades we spotted, 7 were puts, with a value of $1,146,360, and 11 were calls, valued at $2,506,807.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $50.0 to $110.0 for Starbucks over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Starbucks's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Starbucks's whale trades within a strike price range from $50.0 to $110.0 in the last 30 days. 
<h3>Starbucks Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748365239_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SBUX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$18.2</td>
<td>$17.65</td>
<td>$18.2</td>
<td>$80.00</td>
<td>$2.0M</td>
<td>914</td>
<td>372</td>
</tr>
<tr>
<td>SBUX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$3.65</td>
<td>$3.55</td>
<td>$3.58</td>
<td>$80.00</td>
<td>$716.0K</td>
<td>5.7K</td>
<td>2.0K</td>
</tr>
<tr>
<td>SBUX</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>10/17/25</td>
<td>$11.8</td>
<td>$11.6</td>
<td>$11.7</td>
<td>$95.00</td>
<td>$117.0K</td>
<td>198</td>
<td>213</td>
</tr>
<tr>
<td>SBUX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$4.65</td>
<td>$4.6</td>
<td>$4.6</td>
<td>$90.00</td>
<td>$107.6K</td>
<td>791</td>
<td>706</td>
</tr>
<tr>
<td>SBUX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$7.35</td>
<td>$7.3</td>
<td>$7.35</td>
<td>$90.00</td>
<td>$94.0K</td>
<td>165</td>
<td>193</td>
</tr>
</tbody>
</table>

<h3>About Starbucks</h3>
Starbucks is one of the most widely recognized restaurant brands in the world, operating more than 40,000 stores across more than 80 countries as of the end of fiscal 2024. The firm operates in three segments: North America, international markets, and channel development (grocery and ready-to-drink beverage). The coffee chain generates revenue from company-operated stores, royalties, sales of equipment and products to license partners, ready-to-drink beverages, packaged coffee sales, and single-serve products.
Having examined the options trading patterns of Starbucks, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of Starbucks</h3>
<ul>
<li>With a trading volume of 5,566,772, the price of SBUX is up by 2.95%, reaching $86.89.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 63 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Starbucks</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $92.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from JP Morgan has decided to maintain their Overweight rating on Starbucks, which currently sits at a price target of $100. 
&#x2A; An analyst from Barclays has decided to maintain their Overweight rating on Starbucks, which currently sits at a price target of $98. 
&#x2A; Consistent in their evaluation, an analyst from Guggenheim keeps a Neutral rating on Starbucks with a target price of $79. 
&#x2A; Consistent in their evaluation, an analyst from Stifel keeps a Buy rating on Starbucks with a target price of $92. 
&#x2A; Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on Starbucks with a target price of $95. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Starbucks, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

SBUX

Check Out What Whales Are Doing With SBUX

Photronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLAB#NASDAQ">PLAB</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-05-28. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Photronics will report an earnings per share (EPS) of $0.48.
The market awaits Photronics's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Earnings Track Record</h3>
In the previous earnings release, the company beat EPS by $0.05, leading to a 2.44% drop in the share price the following trading session.
Here's a look at Photronics's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.47</td>
<td>0.52</td>
<td>0.56</td>
<td>0.55</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.52</td>
<td>0.59</td>
<td>0.51</td>
<td>0.46</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-2.0%</td>
<td>-6.0%</td>
<td>4.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1748365239_0_0.png" alt="eps graph" />
<h3>Photronics Share Price Analysis</h3>
Shares of Photronics were trading at $19.47 as of May 26. Over the last 52-week period, shares are down 24.85%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/PLAB/earnings">To track all earnings releases for Photronics visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

PLAB

Earnings Preview For Photronics

Investors with a lot of money to spend have taken a bullish stance on Carvana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CVNA, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 61 uncommon options trades for Carvana.
This isn't normal.
The overall sentiment of these big-money traders is split between 60% bullish and 22%, bearish.
Out of all of the special options we uncovered, 29 are puts, for a total amount of $1,748,690, and 32 are calls, for a total amount of $2,197,642.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $150.0 and $460.0 for Carvana, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Carvana's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Carvana's substantial trades, within a strike price spectrum from $150.0 to $460.0 over the preceding 30 days.
<h3>Carvana Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748365234_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CVNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/13/25</td>
<td>$11.6</td>
<td>$9.45</td>
<td>$10.5</td>
<td>$320.00</td>
<td>$690.6K</td>
<td>155</td>
<td align="right">791</td>
</tr>
<tr>
<td>CVNA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$16.15</td>
<td>$16.0</td>
<td>$16.0</td>
<td>$200.00</td>
<td>$320.0K</td>
<td>1.7K</td>
<td align="right">211</td>
</tr>
<tr>
<td>CVNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$18.0</td>
<td>$17.95</td>
<td>$18.0</td>
<td>$390.00</td>
<td>$160.2K</td>
<td>237</td>
<td align="right">10</td>
</tr>
<tr>
<td>CVNA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/21/25</td>
<td>$81.65</td>
<td>$80.75</td>
<td>$81.65</td>
<td>$360.00</td>
<td>$146.9K</td>
<td>200</td>
<td align="right">18</td>
</tr>
<tr>
<td>CVNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$21.85</td>
<td>$20.65</td>
<td>$21.08</td>
<td>$302.50</td>
<td>$105.4K</td>
<td>92</td>
<td align="right">50</td>
</tr>
</tbody>
</table>

<h3>About Carvana</h3>
Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage. The foundation of the business is retail vehicle unit sales. This drives the majority of the revenue and allows the company to capture additional revenue streams associated with financing, VSCs, auto insurance and GAP waiver coverage, as well as trade-in vehicles.
Following our analysis of the options activities associated with Carvana, we pivot to a closer look at the company's own performance.
<h3>Where Is Carvana Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 1,572,073, with CVNA's price up by 2.74%, positioned at $312.43.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 64 days.</li>
</ul>
<h3>Expert Opinions on Carvana</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $320.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Wells Fargo continues to hold a Overweight rating for Carvana, targeting a price of $290. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on Carvana, which currently sits at a price target of $290. 
&#x2A; Consistent in their evaluation, an analyst from Piper Sandler keeps a Overweight rating on Carvana with a target price of $340. 
&#x2A; Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on Carvana with a target price of $340. 
&#x2A; An analyst from Needham downgraded its action to Buy with a price target of $340. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Carvana with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

CVNA

Market Whales and Their Recent Bets on CVNA Options

Applied Digital's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NYSE">APLD</a>) short percent of float has fallen 3.14% since its last report. The company recently reported that it has 62.63 million shares sold short, which is 30.54% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.73 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Applied Digital Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748365229_0_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Applied Digital has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Applied Digital's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Applied Digital's peer group average for short interest as a percentage of float is 6.43%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

APLD

What's Driving the Market Sentiment Around Applied Digital?

UBS analyst Joshua Chan maintains Korn Ferry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFY#NYSE">KFY</a>) with a Neutral and lowers the price target from $75 to $74.

UBS Maintains Neutral on Korn Ferry, Lowers Price Target to $74

Financial giants have made a conspicuous bullish move on Microchip Technology. Our analysis of options history for Microchip Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>) revealed 17 unusual trades.
Delving into the details, we found 47% of traders were bullish, while 41% showed bearish tendencies. Out of all the trades we spotted, 12 were puts, with a value of $681,084, and 5 were calls, valued at $281,540.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $45.0 to $85.0 for Microchip Technology over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Microchip Technology stands at 708.4, with a total volume reaching 3,595.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Microchip Technology, situated within the strike price corridor from $45.0 to $85.0, throughout the last 30 days.
<h3>Microchip Technology 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748365229_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MCHP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/18/26</td>
<td>$14.4</td>
<td>$13.9</td>
<td>$13.9</td>
<td>$65.00</td>
<td>$120.9K</td>
<td>0</td>
<td align="right">87</td>
</tr>
<tr>
<td>MCHP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/18/26</td>
<td>$4.5</td>
<td>$4.1</td>
<td>$4.1</td>
<td>$85.00</td>
<td>$82.0K</td>
<td>0</td>
<td align="right">200</td>
</tr>
<tr>
<td>MCHP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>08/15/25</td>
<td>$3.5</td>
<td>$3.4</td>
<td>$3.5</td>
<td>$55.00</td>
<td>$70.0K</td>
<td>1.0K</td>
<td align="right">720</td>
</tr>
<tr>
<td>MCHP</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$3.5</td>
<td>$3.4</td>
<td>$3.5</td>
<td>$55.00</td>
<td>$70.0K</td>
<td>1.0K</td>
<td align="right">520</td>
</tr>
<tr>
<td>MCHP</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>08/15/25</td>
<td>$3.6</td>
<td>$3.4</td>
<td>$3.5</td>
<td>$55.00</td>
<td>$70.0K</td>
<td>1.0K</td>
<td align="right">200</td>
</tr>
</tbody>
</table>

<h3>About Microchip Technology</h3>
Microchip Technology became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
After a thorough review of the options trading surrounding Microchip Technology, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Microchip Technology</h3>
<ul>
<li>With a trading volume of 3,819,520, the price of MCHP is up by 5.23%, reaching $59.13.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 65 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Microchip Technology</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $58.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Raymond James has revised its rating downward to Strong Buy, adjusting the price target to $65. 
&#x2A; Reflecting concerns, an analyst from Needham lowers its rating to Buy with a new price target of $66. 
&#x2A; An analyst from Citigroup persists with their Buy rating on Microchip Technology, maintaining a target price of $55. 
&#x2A; An analyst from UBS has decided to maintain their Buy rating on Microchip Technology, which currently sits at a price target of $55. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Equal-Weight rating on Microchip Technology, which currently sits at a price target of $50. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Microchip Technology, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

MCHP

Unpacking the Latest Options Trading Trends in Microchip Technology

Regency Centers's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REG#NYSE">REG</a>) short percent of float has risen 9.72% since its last report. The company recently reported that it has 6.17 million shares sold short, which is 4.74% of all regular shares that are available for trading. Based on its trading volume, it would take traders 6.41 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Regency Centers Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748365224_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Regency Centers has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Regency Centers's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Regency Centers's peer group average for short interest as a percentage of float is 5.96%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Do Investors Really Feel About Regency Centers?

WR Berkley's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) short percent of float has fallen 11.19% since its last report. The company recently reported that it has 3.80 million shares sold short, which is 1.27% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.94 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>WR Berkley Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748365219_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for WR Berkley has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing WR Berkley's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, WR Berkley's peer group average for short interest as a percentage of float is 2.50%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

What's Driving the Market Sentiment Around WR Berkley?

In the current session, the stock is trading at $146.69, after a 1.48% increase. Over the past month, Ensign Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSG#NASDAQ">ENSG</a>) stock increased by 15.15%, and in the past year, by 26.36%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1748365218_0.png" alt="Past Year Chart" />

<h3>How Does Ensign Group P/E Compare to Other Companies?</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of 16.33 in the Health Care Providers &amp; Services industry, Ensign Group Inc. has a higher P/E ratio of 27.27. Shareholders might be inclined to think that Ensign Group Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1748365218_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

ENSG

Price Over Earnings Overview: Ensign Group

Oklo Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) co-founder and CEO Jacob DeWitte suggested Tuesday that timelines for the company could potentially be accelerated following multiple executive orders from President Donald Trump aimed at supporting the <a href="https://www.benzinga.com/government/regulations/25/05/45608637/uranium-mining-stocks-rally-after-trumps-nuclear-revival-order-ignites-industry-optimism">domestic nuclear industry</a>.
What Happened: Tuesday on CNBC&#8217;s &#8220;Money Movers,&#8221; DeWitte expressed optimism about the company&#8217;s ability to meet its projected timelines for its nuclear power facilities. He even suggested that regulatory support could allow the company to complete its goals faster than previously expected. 
&#8220;Having the president sign four very significant executive orders shows a pretty big commitment of moving forward, you know, sort of these policy ideas and environment to make it so that nuclear is really going to be inevitable here in the near future,&#8221; DeWitte said.
Trump signed executive orders last week to accelerate advanced nuclear technologies in the U.S. The orders remove regulatory barriers and allow for the rebuilding of a secure domestic nuclear fuel supply chain.
Check This Out: <a href="https://www.benzinga.com/government/regulations/25/05/45608637/uranium-mining-stocks-rally-after-trumps-nuclear-revival-order-ignites-industry-optimism">Uranium Mining Stocks Rally After Trump&#8217;s Nuclear Revival Order Ignites Industry Optimism</a>
Oklo also <a href="https://www.benzinga.com/news/mid-cap/25/05/45618496/oklo-inks-deal-with-south-korean-nuclear-giant-for-global-push">announced a deal</a> on Tuesday with Korea Hydro &amp; Nuclear Power to collaborate on the development and global deployment of Oklo&#8217;s advanced nuclear technology. DeWitte told CNBC that the company has a phenomenal track record of being able to deliver on time and on budget.
The Oklo CEO said the deal is going to be &#8220;accelerative&#8221; for the company both domestically and abroad. Oklo has laid out timelines for deployment of its first nuclear plant in late 2027 or early 2028, but the executive orders combined with the company&#8217;s new collaboration could speed up those timelines. 
He told CNBC that the recent <a href="https://www.benzinga.com/markets/25/05/45583796/nuclear-stocks-oklo-nano-nuclear-constellation-energy-surge-in-friday-pre-market-whats-going-on">flurry of news</a> on the nuclear front has created an environment &#8220;that makes it possible to think even more boldly than what we&#8217;re aiming for.&#8221;
&#8220;We&#8217;ll see, the executive orders obviously are fresh. That opens the door to do things a little bit differently and in new ways perhaps, so we&#8217;re evaluating those and those impacts, but it&#8217;s possible there could be some things that either help firm up those timelines or even move them forward, which would be pretty amazing,&#8221; DeWitte said. 
Nuclear power development has faced significant delays as safety concerns arose following major incidents at global reactor sites, but the need for more power has become increasingly evident as new technologies like AI rapidly increase energy demands. 
&#8220;All of that is going to require a significant frankly nuclear footprint in the country and people see that increasingly. Also people are getting more and more comfortable with the technology,&#8221; DeWitte said. 
Oklo <a href="https://www.benzinga.com/news/earnings/25/05/45392505/oklo-provides-q1-business-update-nuclear-startup-appoints-new-cto-company-says-its-targeting-plant-operations-in-late-2027-early-2028">said</a> earlier this month that it's nearing submission of the Oklo Fuel Foundry LPP to the Nuclear Regulatory Commission, which is the next step in the licensing process for the company&#8217;s commercial fuel fabrication facility. Oklo also recently announced completion of borehole drilling for site characterization work at the Idaho National Laboratory site, the location for the company's first planned Aurora Powerhouse.&nbsp;
OKLO Price Action: <a href="http://benzinga.com/quote/OKLO">Oklo shares</a> jumped 23% on Friday following the nuclear-related executive orders. Shares continued to move higher Tuesday morning on the deal with Korea Hydro &amp; Nuclear Power, and then surged to session highs as DeWitte talked timelines on CNBC. Oklo stock was up 7.69% at $52.65 at the time of publication on Tuesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45616366/nvidias-q1-earnings-loom-while-amds-edge-ai-bet-could-change-the-narrative">Nvidia&#8217;s Q1 Earnings Loom, While AMD&#8217;s Edge AI Bet Could Change The Narrative</a></li>
</ul>
Photo: courtesy of Oklo.

Government

Regulations

Contracts

Oklo CEO Says Recent Developments Surrounding Nuclear Could Move Company Timelines Forward

Builder.ai, the British no-code AI startup once celebrated for its strategic partnership with <a href="https://www.benzinga.com/news/25/05/45260075/apple-teams-up-with-ai-startup-anthropic-to-integrate-claude-sonnet-into-xcode-challenging-microsofts-github-copilot">Microsoft</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) and a $250 million raise led by the Qatar Investment Authority,<a href="https://www.linkedin.com/posts/builderai_today-engineerai-corporation-known-as-activity-7330581919031521280-w7hu/"> announced</a> Tuesday that it is filing for bankruptcy protection.&nbsp;
According to<a href="https://www.bloomberg.com/news/articles/2025-05-20/microsoft-backed-builder-ai-to-enter-insolvency-proceedings"> Bloomberg</a>, the dramatic fall comes after a major lender, Viola Credit, seized $37 million from the company's accounts, leaving just $5 million in restricted funds, effectively paralyzing operations across five countries.
Don't Miss:
<ul class="wp-block-list">
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
CEO Manpreet Ratia replaced founder Sachin Dev Duggal earlier this year in a boardroom shake-up aimed at restoring investor confidence. Ratia said that most of the company's employees have been laid off and that Builder.ai will now begin bankruptcy filings in each of its operational jurisdictions, including the U.K., U.S., UAE, Singapore, and India, Bloomberg reports.
<h2 class="wp-block-heading">Builder.ai Raised $450M Backed by Microsoft, QIA, and WndrCo</h2>
Founded in 2016, <a href="https://www.benzinga.com/news/23/05/32553060/more-money-comes-for-ai-builder-ai-grabs-250m-in-series-d-funding-led-by-qatar-investment-authority">Builder.ai</a> positioned itself as a revolutionary tool for businesses to build custom apps using AI with minimal coding. It raised over $450 million in total funding, attracting marquee investors like Microsoft, the World Bank's IFC, Jeffrey Katzenberg's WndrCo, Lakestar, and SoftBank's DeepCore incubator, Bloomberg reports. In May 2023, Microsoft made an equity investment and<a href="https://www.builder.ai/newsroom/press/builder-ai-announces-collaboration-with-microsoft-to-democratize-software-development"> announced</a> plans to integrate Builder.ai's platform with its own Azure and AI services.
Builder.ai offered a platform that allowed businesses to create custom smartphone apps with little or no coding, aiming to simplify and accelerate the app development process. The company positioned itself as a no-code AI solution, gaining attention during the surge of interest in generative AI, Bloomberg says. However, recent developments signaled deeper challenges within the company's operations.
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a>
Less than two months ago, Builder.ai confirmed it had revised down key sales figures and appointed auditors to examine financials from the past two years. Former employees raised concerns that sales performance had been inflated in previous investor briefings. According to Bloomberg, these allegations triggered a domino effect of investor caution, internal restructuring, and eventual loss of confidence.
<h2 class="wp-block-heading">Investor Hype Meets Harsh Reality</h2>
The turning point came when Viola Credit, which had lent the company $50 million in 2023, seized $37 million from its accounts, leaving Builder.ai unable to meet payroll obligations or continue core operations. The remaining funds, located in Indian accounts, are restricted due to regulatory limitations, Ratia told Bloomberg.
The insolvency proceedings reflect a growing wave of AI startup turbulence. Phil Brunkard, executive counselor at Info-Tech Research Group, told<a href="https://www.computerworld.com/article/3991362/microsoft-backed-no-code-ai-startup-files-for-bankruptcy.html"> Computer World</a> that many AI firms rushed to scale on the back of hype, often lacking strong financial controls or truly differentiated offerings.
See Also: Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000.</a>
<h2 class="wp-block-heading">Bankruptcy Across Borders: A Global Unraveling</h2>
Builder.ai's situation is complicated by its international footprint, Bloomberg reports. Insolvency laws differ across the five regions where it operates, with the U.K. process involving the appointment of a court-approved administrator.
The company said in the LinkedIn statement that it will work closely with administrators to explore options for salvaging parts of the business, while also prioritizing communication with affected employees, customers, and partners.
Builder.ai expressed gratitude to its team and stakeholders in the statement, but acknowledged that past missteps had pushed the company beyond recovery. For a firm once hailed as the future of no-code AI, the collapse may highlight growing scrutiny around startup fundamentals amid the AI investment boom.
Read Next:
<ul class="wp-block-list">
<li>Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.</li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
Image: Shutterstock

MSFT

Builder.ai's Shocking $450M Fall: Microsoft And QIA-Backed No-Code AI Darling Files For Bankruptcy After Creditor Seizure

UBS analyst Karl Keirstead maintains Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) with a Neutral and lowers the price target from $320 to $300.

UBS Maintains Neutral on Salesforce, Lowers Price Target to $300

HOLX

Hologic Shares Resume Trade

Press Releases

MeiraGTx Announces Third Quarter 2024 Financial and Operational Results and Recent Business Updates

Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors

Health Care

MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia

MeiraGTx Receives Rare Pediatric Disease Designation from FDA for AAV8-RK-RetGC for the Treatment of Patients with Leber Congenital Amaurosis due to GUCY2D Mutations

MeiraGTx Announces The Lancet Publication of Data Demonstrating the Efficacy of rAAV8.hRKp.AIPL1 for the Treatment of Leber Congenital Amaurosis 4 (LCA4) Retinal Dystrophy

MeiraGTx Enters into a Strategic Collaboration with Hologen AI to Expedite Phase 3 Development of AAV-GAD for Parkinson's Disease and Industrialize MeiraGTx's Proprietary Manufacturing Process

MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates

MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV-GAD for the Treatment of Parkinson's Disease

MeiraGTx Reports First Quarter 2025 Financial and Operational Results

MeiraGTx Announces the Presentation of Four Posters at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting

Comments

MeiraGTx Hldgs

MeiraGTx Hldgs (MGTX) Opzioni

MeiraGTx Hldgs (NASDAQ:MGTX) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO